As of 2025-10-24, the Relative Valuation of Ultragenyx Pharmaceutical Inc (RARE) is (388.76) USD. This relative valuation is based on P/E multiples. With the latest stock price at 33.63 USD, the upside of Ultragenyx Pharmaceutical Inc based on Relative Valuation is -1256.0%.
The range of the Relative Valuation is (388.76) - (388.76) USD.
Note: valuation result may not be accurate due to the low predictability of business.
| Range | Selected | |
| Trailing P/E multiples | - | - |
| Forward P/E multiples | 70.3x - 70.3x | 70.3x |
| Fair Price | (388.76) - (388.76) | (388.76) |
| Upside | -1256.0% - -1256.0% | -1256.0% |
| Date | P/E |